Isoform specific gene expression analysis of KRAS in the prognosis of lung adenocarcinoma patients
Abstract Background Aberrant mutations in KRAS play a critical role in tumor initiation and progression, and are a negative prognosis factor in lung adenocarcinoma (LUAD). Results Using genomic analysis for K-Ras isoforms (K-Ras4A and K-Ras4B) and large-scale multi-omics data, we inspected the overa...
Main Authors: | In Seok Yang, Sangwoo Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-02-01
|
Series: | BMC Bioinformatics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12859-018-2011-y |
Similar Items
-
Evaluation of KRAS Concomitant Mutations in Advanced Lung Adenocarcinoma Patients
by: Veronica Aran, et al.
Published: (2021-09-01) -
Detection and Analysis of EGFR and KRAS Mutation with Lung Adenocarcinoma
by: Hui ZHANG, et al.
Published: (2015-11-01) -
RANKL acts an unfavorable prognostic biomarker and potential target in advanced KRAS‐mutated lung adenocarcinoma
by: Hong‐Shuai Li, et al.
Published: (2023-05-01) -
Ras isoforms: signaling specificities in CD40 pathway
by: Arathi Nair, et al.
Published: (2020-01-01) -
Small molecular inhibitors for KRAS-mutant cancers
by: Xuan Wu, et al.
Published: (2023-08-01)